Presentation on theme: "Chris Town Chief Executive Greater Peterborough Primary Care Partnership Chair, New Contractual Framework for Community Pharmacy Negotiating Group The."— Presentation transcript:
Chris Town Chief Executive Greater Peterborough Primary Care Partnership Chair, New Contractual Framework for Community Pharmacy Negotiating Group The Implications and Milestones of the New Contractual Framework
Community Pharmacy A Vision for Pharmacy in the new NHS - Community Pharmacy An integral part of the NHS Planning and delivering local services Supporting self-care Responding to diverse needs of patients & communities A Source of innovation in delivery of services Helping to deliver aspirations in NSFs Helping to tackle health inequalities
Community Pharmacy A Proposed New Contractual Framework for Community Pharmacy Why change? Current arrangements in place for nearly two decades Need a framework that better reflects modern service requirements Community pharmacy is an integral part of NHS services What changes? More flexible/versatile, with focus on higher quality services, less on prescription volume Essential, advanced and enhanced/local services Better fit with PCT role in developing local service provision
New Pharmacy Contractual Framework: Benefits Improved patient choice & convenience –eg repeat dispensing and ETP 24/48 hr access target –eg minor ailment schemes Reducing demand on GPs –eg pharmacy led clinics - diabetes
New Pharmacy Contractual Framework: Benefits Chronic disease management –eg medication review, supplementary prescribing, monitoring through near patient testing Supporting delivery of nGMS –quality targets, OoHs, enhanced services Health inequalities & public health –eg drug misuse, smoking cessation
New Pharmacy Contractual Framework: Benefits Improved patient safety –eg learning from patient incidents Better value for money –improved prescribing, reduced waste –medication review: £2 saved for every £1 invested –repeat dispensing : £2.60 - £10.00 saved per patient per month
Pharmacy Contract – Timetable Contract specifications agreed between all parties to the negotiation Three different categories – Essential, Advanced and Supplementary/Enhanced services Negotiation completed re funding levels PSNC consultation 92.5% voted in favour Implementation April 2005
ETP & Better Pharmacy IM&T ETP – electronic transmission of prescriptions between prescriber, dispenser and PPA Read/write access to the patient record Connectivity – e-mail/internet eg NeLH, NPSA, Sharing of patient information is sensitive. –concerns of patients and others the importance of patient consent maintaining confidentiality during data access and transfer
ETP & Better Pharmacy IM&T Discussing with stakeholders need for pharmacists to have access to patient records Role based access Inform consultation on elements of patient information that community pharmacists may need to deliver appropriate healthcare services as part of the proposed new contract Consult shortly Implementation timescale match new contract
New Pharmacy Contractual Framework: Implementation Reflect & link to nGMS Policy collaborative Stakeholder engagement NHS Modernisation Agency & NatPaCT Refocus Medicines Management Collaborative NPC & CPPE
What are we Doing Locally to Prepare? Have set up a strategy group Expanding existing community pharmacy schemes (Pharmacy First) in accordance with local needs Pathfinder site for repeat dispensing – 2 practices involved locally Looking at local service provision and where gaps are – needs assessment
What are we Doing Locally to Prepare? Setting up a register of all pharmacists working locally, including locums Attendance and feedback at PEC and LPC Pharmacy service provision needs to go into LDP Learning needs being identified and standardised competency assessments being carried out
Implications for the Pharma Industry Pharmacists as prescribers - both independent and supplementary ? Will this lead to more POM to P switches ? Greater role for Pharmacists in Chronic disease management ? Impact of medication reviews ? Formulary development as part of closer links with G.Ps ?
Your consent to our cookies if you continue to use this website.